Androgen deprivation therapy (ADT) is a common practice for the treatment of advanced prostate cancer (PCa) since its discovery by Huggins and Hodges in 1941 [1], which involves surgical castration such as bilateral orchiectomy or chemical castration such as inhibition of androgen receptor (AR). The gene discussed is AR; the disease is prostate cancer.